Danaher Corporation (DHR)
NYSE: DHR · IEX Real-Time Price · USD
273.91
+3.82 (1.41%)
At close: Jul 26, 2024, 4:00 PM
274.05
+0.14 (0.05%)
After-hours: Jul 26, 2024, 7:02 PM EDT
Danaher Employees
Danaher had 63,000 employees as of December 31, 2023. The number of employees decreased by 18,000 or -22.22% compared to the previous year.
Employees
63,000
Change (1Y)
-18,000
Growth (1Y)
-22.22%
Revenue / Employee
$335,000
Profits / Employee
$66,714
Market Cap
197.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 63,000 | -18,000 | -22.22% |
Dec 31, 2022 | 81,000 | 1,000 | 1.25% |
Dec 31, 2021 | 80,000 | 11,000 | 15.94% |
Dec 31, 2020 | 69,000 | 9,000 | 15.00% |
Dec 31, 2019 | 60,000 | -11,000 | -15.49% |
Dec 31, 2018 | 71,000 | 4,000 | 5.97% |
Dec 31, 2017 | 67,000 | 5,000 | 8.06% |
Dec 31, 2016 | 62,000 | -19,000 | -23.46% |
Dec 31, 2015 | 81,000 | 10,000 | 14.08% |
Dec 31, 2014 | 71,000 | 5,000 | 7.58% |
Dec 31, 2013 | 66,000 | 3,000 | 4.76% |
Dec 31, 2012 | 63,000 | 4,000 | 6.78% |
Dec 31, 2011 | 59,000 | 10,800 | 22.41% |
Dec 31, 2010 | 48,200 | 1,600 | 3.43% |
Dec 31, 2009 | 46,600 | -3,700 | -7.36% |
Dec 31, 2008 | 50,300 | 300 | 0.60% |
Dec 31, 2007 | 50,000 | 5,000 | 11.11% |
Dec 31, 2006 | 45,000 | 5,000 | 12.50% |
Dec 31, 2005 | 40,000 | 5,000 | 14.29% |
Dec 31, 2004 | 35,000 | 5,000 | 16.67% |
Dec 31, 2003 | 30,000 | 1,000 | 3.45% |
Dec 31, 2002 | 29,000 | 6,000 | 26.09% |
Dec 31, 2001 | 23,000 | -1,000 | -4.17% |
Dec 31, 2000 | 24,000 | 5,000 | 26.32% |
Dec 31, 1999 | 19,000 | 1,000 | 5.56% |
Dec 31, 1998 | 18,000 | 4,800 | 36.36% |
Dec 31, 1997 | 13,200 | 1,600 | 13.79% |
Dec 31, 1996 | 11,600 | 1,100 | 10.48% |
Dec 31, 1995 | 10,500 | 540 | 5.42% |
Dec 31, 1994 | 9,960 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Pfizer | 88,000 |
Sanofi | 86,088 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
AbbVie | 50,000 |
DHR News
- 1 day ago - Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration - PRNewsWire
- 3 days ago - Danaher Stock Soars on Q2 Earnings Beat - Investopedia
- 3 days ago - Danaher Stock Surges. More Than Earnings Are Driving It Higher. - Barrons
- 3 days ago - Danaher beats Q2 profit estimates on strength in medical testing business - Reuters
- 3 days ago - Danaher Reports Second Quarter 2024 Results - PRNewsWire
- 9 days ago - Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development - PRNewsWire
- 10 days ago - Danaher Releases 2024 Sustainability Report - PRNewsWire
- 15 days ago - Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening - PRNewsWire